Patent details

EP3350183 Title: SOLID FORMS OF ISOQUINOLINONE DERIVATIVES, PROCESS OF MAKING, COMPOSITIONS COMPRISING, AND METHODS OF USING THE SAME

Basic Information

Publication number:
EP3350183
PCT Application Number:
US2016051490
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP167668276
PCT Publication Number:
WO2017048702
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SOLID FORMS OF ISOQUINOLINONE DERIVATIVES, PROCESS OF MAKING, COMPOSITIONS COMPRISING, AND METHODS OF USING THE SAME
French Title of Invention:
FORMES SOLIDES DE DÉRIVÉS D'ISOQUINOLINONE, LEUR PROCÉDÉ DE FABRICATION, COMPOSITIONS LES COMPRENANT ET MÉTHODES D'UTILISATION DE CELLES-CI
German Title of Invention:
FESTE FORMEN VON ISOCHINOLINONDERIVATEN, HERSTELLUNGSVERFAHREN, ZUSAMMENSETZUNGEN DAMIT UND VERWENDUNGSVERFAHREN DAFÜR
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
29/04/2025
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
07/05/2025
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
02/04/2025
Unitary Effect Registration Date:
07/05/2025
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
10/12/2009
Grant date:
02/04/2025
EP Publication Date:
25/07/2018
PCT Publication Date:
23/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/04/2025
EP B1 Publication Date:
02/04/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/03/2025
 
 

Name:
Twelve Therapeutics, Inc.
Address:
345 Park Avenue South, 12th Floor, New York, NY 10010, United States (US)

Inventor

1

Name:
SHARMA, Praveen
Address:
United States (US)

2

Name:
GRENIER, Louis
Address:
United States (US)

3

Name:
LESCARBEAU, Andre
Address:
United States (US)

4

Name:
GENOV, Daniel G.
Address:
United States (US)

Priority

1

Priority Number:
201562218486 P
Priority Date:
14/09/2015
Priority Country:
United States (US)

2

Priority Number:
201562218493 P
Priority Date:
14/09/2015
Priority Country:
United States (US)

Classification

IPC classification:
C07D 487/04; A61K 31/519; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202514
Publication date:
02/04/2025
Description:
Grant (B1)

2

Issue number:
202518
Publication date:
30/04/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202523
Publication date:
04/06/2025
Description:
Unitary Effect Request Receipt

4

Issue number:
202523
Publication date:
04/06/2025
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages